Allegro Receives FDA Agreement Under SPA for Phase 2b/3 Trial of Risuteganib
12 Apr 2023 //
PR NEWSWIRE
Hanmi transfers rights for retinal disease drug to Chinese partner
03 Jan 2022 //
KOREABIOMED
12 Apr 2023 //
PR NEWSWIRE
03 Jan 2022 //
KOREABIOMED